Soluble monomeric acetylcholinesterase from mouse: Expression, purification, and crystallization in complex with fasciculin

Protein Science

Volumn 5, Issue 4, 1996, Pages 672-679

  Marchot, Pascale ^a,f   Ravelli, Raimond B G ^b   Raves, Mia L ^c,e   Bourne, Yves ^a,d,g   Vellom, Daniel C ^a,h   Kanter, Joan ^a   Camp, Shelley ^a   Sussman, Joel L ^c,e   Taylor, Palmer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^f AIX MARSEILLE UNIVERSITY   (France)

^g CNRS   (France)

^h CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

acetylcholinesterase; crystallization; fasciculin; peptide macromolecule complex; snake toxin

Indexed keywords

ACETYLCHOLINESTERASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; COMPLEMENTARY DNA; FASCICULIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; ENZYME BINDING; ENZYME ISOLATION; ENZYME PURIFICATION; ENZYME STRUCTURE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0029874624     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050411     Document Type: Article

References (35)

1. Adem A, Asblom A, Johansson G, Mbugua PM, Karlsson E. 1988. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinylbenzylate to muscarinic acetylcholine receptors. Biochim Biophys Acta 968:340-345.
2. Bougis P, Rochat H, Piéroni G, Verger R. 1981. Penetration of phospholipid monolayers by cardiotoxins. Biochemistry 20:4915-4920.
3. Bourne Y, Taylor P, Marchot P. 1995. Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex. Cell 83:503-512.
4. Camp S, Bon S, Li Y, Getman DK, Engel AG, Massoulié J, Taylor P. 1995. Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits. J Clin Invest 95:333-340.
5. Cerveñansky C, Dajas F, Harvey AL, Karlsson E. 1991. Fasciculins, anticholinesterase toxins from mamba venoms: Biochemistry and pharmacology. In: Harvey AL, ed. Snake toxins. New York: Pergamon Press Inc. pp 303-321.
6. Changeux JP, Kasai M, Lee CY. 1970. The use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci USA 67:1241-1247.
7. Dufton MJ, Hider RC. 1991. The structure and pharmacology of elapid cytotoxins. In: Harvey AL, ed. Snake toxins. New York: Pergamon Press Inc. pp 259-302.
8. Duval NE, Krejci E, Grassi J, Coussen F, Massoulié J, Bon S. 1992. Molecular architecture of acetylcholinesterase collagen-tailed forms; construction of a glycolipid-tailed tetramer. EMBO J 11:3255-3261.
9. Eastman J, Wilson EJ, Cerveñansky C, Rosenberry TL. 1995. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation. J Biol Chem 270:19694-19701.
10. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. 1961. A new rapid combination method for acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
11. Endo T, Tamiya N. 1991. Structure-function relationship of postsynaptic neurotoxins from snake venoms. In: Harvey AL, ed. Snake toxins. New York: Pergamon Press Inc. pp 165-222.
12. Harel M, Kleywegt GJ, Ravelli RBG, Silman I, Sussman JL. 1995. Crystal structure of an acetylcholinesterase-fasciculin complex: Interaction of a three-fingered toxin from snake venom with its target. Structure 3: 1355-1366.
13. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
14. Le Du MH, Housset D, Marchot P, Bougis PE, Navaza J, Fontecilla-Camps JC. 1996. Crystal structure of fasciculin 2 from mamba snake venom: Evidence for unusual loop flexibility. Acta Crystallogr D52:8.
15. Le Du MH, Marchot P, Bougis PE, Fontecilla-Camps JC. 1989. Crystals of fasciculin 2 from green mamba snake venom: Preparation and preliminary X-ray analysis. J Biol Chem 264:21401-21402.
16. Le Du MH, Marchot P, Bougis PE, Fontecilla-Camps JC. 1992. 1.9 Å resolution structure of fasciculin 1, an anti-cholinesterase toxin from green mamba snake venom. J Biol Chem 267:22122-22130.
17. Li Y, Camp S, Rachinsky TL, Getman D, Taylor P. 1991. Gene structure of mammalian acetylcholinesterase. J Biol Chem 266:23083-23090.
18. Li Y, Camp S, Taylor P. 1993. Tissue-specific expression and alternative mRNA processing of the mammalian acetylcholinesterase gene. J Biol Chem 268:5790-5797.
19. 125I-fasciculin to rat brain acetylcholinesterase. The complex still binds diisopropyl fluorophosphate. J Biol Chem 268:12458-12467.
20. Massoulié J, Pezzementi L, Bon S, Krejci E, Vallette FM. 1993. Molecular and cellular biology of the cholinesterases. Prog Neurobiol 41:31-91.
21. Matthews BW. 1968. Solvent content of protein crystals. J Mol Biol 33: 491-497.
22. Morrisey J. 1981. Silver stain for proteins in polyacrylamide gels; a modified procedure with enhanced uniform sensitivity. Anal Biochem 117:307-310.
23. Rachinsky TL, Camp S, Li Y, Ekström J, Newton M, Taylor P. 1990 Molecular cloning of mouse acetylcholinesterase: Tissue distribution of alternatively spliced mRNA species. Neuron 5:317-327.
24. Radić Z, Duran R, Vellom DC, Li Y, Cerveñansky C, Taylor P. 1994. Site of fasciculin interaction with acetylcholinesterase. J Biol Chem 269: 11233-11239.
25. Radić Z, Pickering NA, Vellom DC, Camp S, Taylor P. 1993. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 32:12074-12084.
26. Radić Z, Quinn DM, Vellom DC, Camp S, Taylor P. 1995. Allosteric control of acetylcholinesterase catalysis by fasciculin. J Biol Chem 270:20391-20399.
27. Segalas I, Roumestand C, Zinn-Justin S, Gilquin B, Ménez R, Ménez A, Toma F. 1995. Solution structure of a green mamba toxin that activates muscarinic acetylcholine receptors, as studied by nuclear magnetic resonance and molecular modeling. Biochemistry 34:1248-1260.
28. Stura E, Wilson IA. 1992 Seeding techniques. In: Ducruix A, Giege R, eds. Crystallization of nucleic acids and proteins, a practical approach. Oxford: IRL Press, Oxford University Press. pp 99-126.
29. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. 1991. Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science 253:872-879.
30. Sussman JL, Harel M, Frolow F, Varon L, Toker L, Futerman AH, Silman I. 1988. Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C. J Mol Biol 203:821-823.
31. Taylor P, Jacobs NM. 1974. Interaction between bisquaternary ammonium ligands and acetylcholinesterase: Complex formation studied by fluorescence quenching. Mol Pharmacol 10:93-107.
32. Taylor P, Radic Z. 1994. The cholinesterases: From genes to proteins. Annu Rev Pharmacol Toxicol 34:281-320.
33. van den Born HKL, Radić Z, Marchot P, Taylor P, Tsigelny I. 1995. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase. Protein Sci 4:703-715.
34. Velan B, Kronman C, Leitner M, Grosfeld H, Flashner Y, Marcus D, Lazar A, Kerem A, Bar-Nun S, Cohen S, Shafferman A. 1992. Molecular organization of recombinant human acetylcholinesterase. In: Shafferman A, Velan B, eds. Multidisciplinary approches 10 cholinesterase functions. New York: Plenum Press. pp 39-47.
35. Vellom DC, Radić Z, Li Y, Pickering NA, Camp S, Taylor P. 1993. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry 32:12-17.